Primary vs Secondary Sjögren's: What's the Difference?
Published: | Updated:
Primary Sjögren's syndrome occurs on its own as an independent disease, while secondary Sjögren's happens alongside another autoimmune condition like rheumatoid arthritis or lupus. Primary Sjögren's does not turn into secondary, but both forms cause severe dryness in the eyes and mouth.
Key Takeaways
- • Primary Sjögren's syndrome occurs as a standalone autoimmune disease, while secondary Sjögren's occurs alongside another condition like rheumatoid arthritis or lupus.
- • Primary Sjögren's does not turn into secondary Sjögren's, though patients have a higher risk of eventually developing a second autoimmune disease.
- • Treatment for primary Sjögren's is tailored specifically to the disease, whereas secondary Sjögren's management prioritizes controlling the underlying primary condition.
- • Both forms of the disease cause severe dryness in the eyes and mouth, also known as sicca symptoms.
- • Patients should promptly report new symptoms like joint pain, rashes, or shortness of breath to their rheumatologist to monitor for disease progression.
If you have just been diagnosed with Sjögren’s syndrome, you might hear the terms “Primary” and “Secondary.” The difference is straightforward: Primary Sjögren’s syndrome occurs on its own, without any other underlying autoimmune rheumatic disease [1][2]. Secondary Sjögren’s syndrome means that your Sjögren’s symptoms are occurring alongside another established autoimmune disease that you already have, most commonly Rheumatoid Arthritis (RA) or Systemic Lupus Erythematosus (SLE) [3][4].
Note on terminology: While doctors still commonly use the terms “Primary” and “Secondary,” newer medical guidelines have started shifting away from these labels. You might see Secondary Sjögren’s written in your medical chart as “Sjögren’s associated with Rheumatoid Arthritis,” for example, to reflect that Sjögren’s is a distinct disease and not subordinate to the other condition.
Many newly diagnosed patients wonder if having Primary Sjögren’s means they will eventually develop another autoimmune disease. While there is an increased risk, it is important to know that this is not a guarantee. The majority of people with Primary Sjögren’s will only ever have Primary Sjögren’s. It is a complete, distinct systemic disease of its own [1][3], and many patients live full, active lives by successfully managing their symptoms. The diagnostic tests used to confirm both types—such as checking your blood for autoantibodies (like SSA/Ro) or performing a lip biopsy—are generally the same [2].
Let’s break down the key differences between the two forms.
Does Primary Sjögren’s Turn Into Secondary Sjögren’s?
A common point of confusion is whether Primary Sjögren’s is just an “early stage” of another disease. Primary Sjögren’s does not “turn into” Secondary Sjögren’s. It is a distinct, independent disease with its own underlying biological processes [5].
However, autoimmune diseases can sometimes cluster together, a concept known as polyautoimmunity [6][7]. Patients diagnosed with Primary Sjögren’s do have a higher risk of subsequently developing another autoimmune condition like Lupus or Rheumatoid Arthritis compared to the general population [3]. Because of this risk, your rheumatologist will monitor you over time for any new symptoms that might suggest a second overlapping condition [3][8].
Symptom Severity and Disease Progression
While both types cause significant dryness in the eyes and mouth (sicca symptoms), the way the disease progresses and affects the rest of your body can look different.
- Primary Sjögren’s: Because it is a standalone systemic disease, it can affect more than just your moisture-producing glands. In a subset of patients, Primary Sjögren’s can involve other organs, including the lungs, kidneys, and nervous system [1][9]. For example, it can cause inflammation in the kidneys or lungs [10][11]. It is important to remember that severe organ damage is not a guaranteed or expected outcome for everyone; many patients only ever experience dryness and fatigue. Patients with Primary Sjögren’s also have an independently elevated risk of developing certain types of lymphoma [12][13]. While hearing the word “lymphoma” can be scary, this complication only occurs in a small percentage of patients, and your doctor will monitor your bloodwork for early warning signs [14][8].
- Secondary Sjögren’s: The overall disease progression is usually driven by the “primary” underlying disease (like Lupus or Rheumatoid Arthritis) [15]. The glandular inflammation in Secondary Sjögren’s actually has a distinct disease process from Primary Sjögren’s [5]. For these patients, the systemic damage to organs or joints is typically caused by the RA or Lupus, with Sjögren’s adding the challenge of severe dryness.
Differences in Treatment Approaches
Because the driving forces behind Primary and Secondary Sjögren’s differ, the medical approach to treating them differs as well [15].
- Treating Primary Sjögren’s: Treatment is tailored specifically to this disease. It focuses on relieving the severe dryness using specific treatments (like specialized prescription eye drops or saliva-stimulating medications such as pilocarpine). If internal organs become involved, doctors may use immunosuppressive drugs (medications that reduce the immune system’s overall activity) to calm the inflammation and prevent damage [14][16].
- Treating Secondary Sjögren’s: In Secondary Sjögren’s, medical management usually prioritizes treating the underlying Rheumatoid Arthritis, Lupus, or other primary condition [15][17]. Controlling the “main” disease is the priority. However, treating the underlying disease does not consistently relieve the Sjögren’s dryness symptoms, meaning you will still need targeted symptom relief for your dry eyes and dry mouth [17].
What Symptoms to Watch For
Because your condition can evolve, it is important to be an active participant in your care. Contact your rheumatologist between appointments if you develop new or worsening symptoms that could suggest systemic organ involvement or a second autoimmune condition. Red flags to watch for include:
- New, severe, or worsening joint pain and swelling
- Unexplained skin rashes, especially purple spots on your legs
- New or worsening shortness of breath or a chronic dry cough
- Persistent swelling of your salivary glands (in your cheeks or under your jaw)
- Extreme, unexplained changes in your fatigue levels or new neurological symptoms like numbness or balance issues
Frequently Asked Questions
What is the difference between primary and secondary Sjögren's?
Does primary Sjögren's turn into secondary Sjögren's?
Is the treatment the same for primary and secondary Sjögren's?
What symptoms should I watch out for with primary Sjögren's?
Questions for Your Doctor
- • Given my current symptoms and bloodwork, what is my personal risk for developing systemic organ involvement?
- • What specific routine bloodwork and screening schedule will I be on to monitor for other autoimmune diseases or lymphoma?
- • If I develop new symptoms, such as joint pain or a rash, what is the best way to report these to your office between appointments?
- • Should I be seeing any other specialists, such as an ophthalmologist or pulmonologist, as part of my routine care team?
Questions for You
- • What symptoms initially led to my diagnosis, and have I noticed any new symptoms (like joint pain or shortness of breath) since then?
- • Has anyone in my direct biological family been diagnosed with an autoimmune disease like Lupus or Rheumatoid Arthritis?
- • How is my current level of dryness affecting my daily life, and are my current symptom management strategies working?
Want personalized information?
Type your question below to get evidence-based answers tailored to your situation.
References
- 1
Renal Disease in Primary Sjögren's Syndrome.
Aiyegbusi O, McGregor L, McGeoch L, et al.
Rheumatology and therapy 2021; (8(1)):63-80 doi:10.1007/s40744-020-00264-x.
PMID: 33367966 - 2
Primary Sjögren's syndrome.
Bowman SJ
Lupus 2018; (27(1_suppl)):32-35 doi:10.1177/0961203318801673.
PMID: 30452329 - 3
Increased Risk of Developing Systemic Lupus Erythematosus and Rheumatoid Arthritis in Patients with Primary Sjögren's Syndrome-A Secondary Cohort Analysis of Nationwide, Population-Based Claims Data.
Koo M, Hsu CW, Lu MC
Journal of clinical medicine 2023; (12(12)) doi:10.3390/jcm12124157.
PMID: 37373849 - 4
Comorbidities in Patients With Primary Sjögren's Syndrome and Systemic Lupus Erythematosus: A Comparative Registries-Based Study.
Rúa-Figueroa I, Fernández Castro M, Andreu JL, et al.
Arthritis care & research 2017; (69(1)):38-45 doi:10.1002/acr.23015.
PMID: 27564390 - 5
Analysis of the cell populations composing the mononuclear cell infiltrates in the labial minor salivary glands from patients with rheumatoid arthritis and sicca syndrome.
Fragoulis GE, Fragkioudaki S, Reilly JH, et al.
Journal of autoimmunity 2016; (73()):85-91.
PMID: 27344240 - 6
Hypophysitis and central nervous system involvement in association with Sjögren's syndrome along with hypoparathyroidism: a case report.
Yum J, Lee SW, Rhee Y, Heo K
BMC neurology 2024; (24(1)):339 doi:10.1186/s12883-024-03845-3.
PMID: 39261772 - 7
Systematic review and meta-analysis of the epidemiology of polyautoimmunity in Sjögren's syndrome (secondary Sjögren's syndrome) focusing on autoimmune rheumatic diseases.
Alani H, Henty JR, Thompson NL, et al.
Scandinavian journal of rheumatology 2018; (47(2)):141-154 doi:10.1080/03009742.2017.1324909.
PMID: 28927315 - 8
Male patients with primary Sjögren's syndrome have unique clinical manifestations and circulating lymphocyte profiles.
Liu H, Yuan J, Tan X, et al.
Clinical rheumatology 2024; (43(6)):1927-1937 doi:10.1007/s10067-024-06955-y.
PMID: 38602613 - 9
Current State of Knowledge on Primary Sjögren's Syndrome, an Autoimmune Exocrinopathy.
Parisis D, Chivasso C, Perret J, et al.
Journal of clinical medicine 2020; (9(7)) doi:10.3390/jcm9072299.
PMID: 32698400 - 10
Renal Involvement in Primary Sjögren's Syndrome: A Multi-centric Study From North India.
Sanjeevani S, Prasad P, Sharma S, et al.
Cureus 2025; (17(6)):e86494 doi:10.7759/cureus.86494.
PMID: 40693062 - 11
Prevalence and risk factors of interstitial lung disease in patients with primary Sjögren's syndrome: A systematic review and meta-analysis.
He C, Chen Z, Liu S, et al.
International journal of rheumatic diseases 2020; (23(8)):1009-1018 doi:10.1111/1756-185X.13881.
PMID: 32588976 - 12
Characteristics of diffuse large B-cell lymphoma in patients with primary Sjögren's syndrome.
Gorodetskiy VR, Probatova NA, Vasilyev VI
International journal of rheumatic diseases 2020; (23(4)):540-548 doi:10.1111/1756-185X.13800.
PMID: 32100426 - 13
Chronic Epstein-Barr virus infection: A potential junction between primary Sjögren's syndrome and lymphoma.
Yang L, Pu J, Cai F, et al.
Cytokine 2023; (168()):156227 doi:10.1016/j.cyto.2023.156227.
PMID: 37244248 - 14
Predicting lymphoma development in patients with Sjögren's syndrome.
De Vita S, Gandolfo S
Expert review of clinical immunology 2019; (15(9)):929-938 doi:10.1080/1744666X.2019.1649596.
PMID: 31347413 - 15
Targeting primary Sjögren's syndrome.
Odani T, Chiorini JA
Modern rheumatology 2019; (29(1)):70-86 doi:10.1080/14397595.2018.1546268.
PMID: 30424703 - 16
Primary Sjögren's Syndrome.
Mariette X, Criswell LA
The New England journal of medicine 2018; (378(10)):931-939 doi:10.1056/NEJMcp1702514.
PMID: 29514034 - 17
Diagnosis and management of lung involvement in systemic lupus erythematosus and Sjögren's syndrome: a literature review.
Depascale R, Del Frate G, Gasparotto M, et al.
Therapeutic advances in musculoskeletal disease 2021; (13()):1759720X211040696 doi:10.1177/1759720X211040696.
PMID: 34616495
This page explains the differences between primary and secondary Sjögren's syndrome for educational purposes only. Always consult your rheumatologist for personalized diagnosis, disease monitoring, and treatment.
Stay up to date
Get notified when new research about Primary Sjögren's Syndrome is published.
No spam. Unsubscribe anytime.